Added Benefit of Covid-19 Vaccination After Previous Infection

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2022 Mar 30

PMID 35353966

Authors

Nicola P Klein

Affiliations

Soon will be listed here.

Citing Articles

Quantitative SARS-CoV-2 Spike Receptor-Binding Domain and Neutralizing Antibody Titers in Previously Infected Persons, United States, January 2021-February 2022.

Bratcher A, Kao S, Chun K, Petropoulos C, Gundlapalli A, Jones J Emerg Infect Dis. 2024; 30(11):2352-2361.

PMID: 39447163 PMC: 11521179. DOI: 10.3201/eid3011.240043.

Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries.

Arsenault C, Lewis T, Kapoor N, Okiro E, Leslie H, Armeni P Lancet Glob Health. 2023; 12(1):e156-e165.

PMID: 38096888 PMC: 10716622. DOI: 10.1016/S2214-109X(23)00490-4.

Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers.

Bansal A, Trieu M, Mohn K, Madsen A, Olofsson J, Sandnes H Front Public Health. 2023; 11:1164326.

PMID: 37546332 PMC: 10402899. DOI: 10.3389/fpubh.2023.1164326.

Determinants of Covid-19 vaccination: Evidence from the US pulse survey.

Roy A PLOS Glob Public Health. 2023; 3(5):e0001927.

PMID: 37200233 PMC: 10194978. DOI: 10.1371/journal.pgph.0001927.

Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis.

Contractor A, Shivaprakash S, Tiwari A, Setia M, Gianchandani T PLoS One. 2022; 17(10):e0276759.

PMID: 36301977 PMC: 9612509. DOI: 10.1371/journal.pone.0276759.

References

Vitale J, Mumoli N, Clerici P, De Paschale M, Evangelista I, Cei M . Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy. JAMA Intern Med. 2021; 181(10):1407-1408. PMC: 8164145. DOI: 10.1001/jamainternmed.2021.2959. View

Thompson M, Natarajan K, Irving S, Rowley E, Griggs E, Gaglani M . Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August.... MMWR Morb Mortal Wkly Rep. 2022; 71(4):139-145. PMC: 9351525. DOI: 10.15585/mmwr.mm7104e3. View

Hammerman A, Sergienko R, Friger M, Beckenstein T, Peretz A, Netzer D . Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19. N Engl J Med. 2022; 386(13):1221-1229. PMC: 8908846. DOI: 10.1056/NEJMoa2119497. View

Leon T, Dorabawila V, Nelson L, Lutterloh E, Bauer U, Backenson B . COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021. MMWR Morb Mortal Wkly Rep. 2022; 71(4):125-131. PMC: 9351527. DOI: 10.15585/mmwr.mm7104e1. View

Ferdinands J, Rao S, Dixon B, Mitchell P, DeSilva M, Irving S . Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10.... MMWR Morb Mortal Wkly Rep. 2022; 71(7):255-263. PMC: 8853475. DOI: 10.15585/mmwr.mm7107e2. View